International, Multicentre, Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Extension of PRISM Study I10E-1302"

Trial Profile

International, Multicentre, Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Extension of PRISM Study I10E-1302"

Discontinued
Phase of Trial: Phase III

Latest Information Update: 05 Dec 2017

At a glance

  • Drugs Immune globulin (Primary)
  • Indications Chronic inflammatory demyelinating polyradiculoneuropathy
  • Focus Therapeutic Use
  • Acronyms PRISM2
  • Sponsors LFB Biotechnologies
  • Most Recent Events

    • 30 Nov 2017 Status changed from recruiting to discontinued.
    • 13 Nov 2017 This trial was discontinued in France (end date: 2017-07-28), according to European Clinical Trials Database.
    • 02 Aug 2017 This study has been discontinued in Germany as per European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top